FDANonrulemakingFDA-2018-D-1456
Who commented on this docket
Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-the-Counter Monograph: Study Elements and Considerations; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-the-Counter Monograph: Study Elements and Considerations; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2927d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 2927d ago
Commenters (1)
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.